|
Volumn 34, Issue 3, 2008, Pages 339-340
|
Intracameral medication: Is it worth the risk?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADRENALIN;
BENZALKONIUM CHLORIDE;
BUPIVACAINE;
CEFUROXIME;
GENTAMICIN;
LIDOCAINE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
VANCOMYCIN;
ANTIINFECTIVE AGENT;
EYE DROPS;
PRESERVATIVE;
ANTERIOR EYE CHAMBER;
CATARACT EXTRACTION;
DOSE RESPONSE;
DRUG EFFICACY;
EDITORIAL;
ENDOPHTHALMITIS;
ENDOTHELIUM LESION;
EYE CARE;
HUMAN;
PRIORITY JOURNAL;
UNSPECIFIED SIDE EFFECT;
ANTIBIOTIC PROPHYLAXIS;
DRUG EFFECT;
LENS IMPLANTATION;
NOTE;
PH;
PHACOEMULSIFICATION;
RISK FACTOR;
ANTERIOR CHAMBER;
ANTI-BACTERIAL AGENTS;
ANTIBIOTIC PROPHYLAXIS;
ENDOPHTHALMITIS;
HUMANS;
HYDROGEN-ION CONCENTRATION;
LENS IMPLANTATION, INTRAOCULAR;
OPHTHALMIC SOLUTIONS;
PHACOEMULSIFICATION;
PRESERVATIVES, PHARMACEUTICAL;
RISK FACTORS;
|
EID: 41949108540
PISSN: 08863350
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jcrs.2008.01.001 Document Type: Editorial |
Times cited : (18)
|
References (4)
|